Author:
Fusco Nicola,Vaira Valentina,Righi Ilaria,Sajjadi Elham,Venetis Konstantinos,Lopez Gianluca,Cattaneo Margherita,Castellani Massimo,Rosso Lorenzo,Nosotti Mario,Clerici Mario,Ferrero Stefano
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference41 articles.
1. GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries - Bray - 2018 - CA: a Cancer journal for Clinicians;Global cancer statistics,2018
2. Current treatments and trials in malignant pleural mesothelioma;Bibby;Clin. Respir. J.,2018
3. Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer audit in England and Wales;Beckett;Lung Cancer,2015
4. the immune microenvironment in mesothelioma: mechanisms of resistance to immunotherapy;Chu;Front. Oncol.,2019
5. Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial;Maio;Lancet Oncol.,2017
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献